BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23794253)

  • 1. Potential clinical significance of ERβ ON promoter methylation in sporadic breast cancer.
    Božović A; Markićević M; Dimitrijević B; Jovanović Ćupić S; Krajnović M; Lukić S; Mandušić V
    Med Oncol; 2013; 30(3):642. PubMed ID: 23794253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of promoter methylation of ERα and ERβ with sporadic breast cancer--a study from North India.
    Chattopadhyay S; Deo SV; Shukla NK; Husain SA
    Tumour Biol; 2014 Aug; 35(8):7911-9. PubMed ID: 24833090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implications of ERβ methylation on sporadic breast cancers in Chinese women.
    Zhao L; Yu Z; Li Y; Wen X; Ma W; Wang L; Ren J; Liu C; He M; Bai X; Sun M; Zheng Z; Mi X; Wang E; Olopade OI; Jin F; Wei M
    Med Oncol; 2012 Sep; 29(3):1569-75. PubMed ID: 22105146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of estrogen receptor beta wt isoform (ERbeta1) and ERbetaDelta5 splice variant mRNAs in sporadic breast cancer.
    Mandusić V; Nikolić-Vukosavljević D; Tanić N; Kanjer K; Neskovic-Konstantinović Z; Celeketić D; Dimitrijević B
    J Cancer Res Clin Oncol; 2007 Aug; 133(8):571-9. PubMed ID: 17457609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation.
    Zhao C; Lam EW; Sunters A; Enmark E; De Bella MT; Coombes RC; Gustafsson JA; Dahlman-Wright K
    Oncogene; 2003 Oct; 22(48):7600-6. PubMed ID: 14576822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CpG methylation of the ERalpha and ERbeta genes in breast cancer.
    Kim SJ; Kim TW; Lee SY; Park SJ; Kim HS; Chung KW; Lee ES; Kang HS
    Int J Mol Med; 2004 Aug; 14(2):289-93. PubMed ID: 15254780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of estrogen receptor β1 expression in breast cancer by epigenetic modification of the 5' regulatory region.
    Al-Nakhle H; Smith L; Bell SM; Burns PA; Cummings M; Hanby AM; Lane S; Parker MD; Hughes TA; Speirs V
    Int J Oncol; 2013 Dec; 43(6):2039-45. PubMed ID: 24068253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer.
    Li W; Jia M; Qin X; Hu J; Zhang X; Zhou G
    FEBS J; 2013 Dec; 280(23):6128-40. PubMed ID: 24103091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor-alpha promoter methylation in sporadic basal-like breast cancer of Chinese women.
    Jing MX; Mao XY; Li C; Wei J; Liu C; Jin F
    Tumour Biol; 2011 Aug; 32(4):713-9. PubMed ID: 21625942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progesterone receptor B (PRB) promoter hypermethylation in sporadic breast cancer: progesterone receptor B hypermethylation in breast cancer.
    Mc Cormack O; Chung WY; Fitzpatrick P; Cooke F; Flynn B; Harrison M; Fox E; Gallagher E; McGoldrick A; Dervan PA; McCann A; Kerin MJ
    Breast Cancer Res Treat; 2008 Sep; 111(1):45-53. PubMed ID: 17896177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different associations of estrogen receptor β isoforms, ERβ1 and ERβ2, expression levels with tumor size and survival in early- and late-onset breast cancer.
    Mandusic V; Dimitrijevic B; Nikolic-Vukosavljevic D; Neskovic-Konstantinovic Z; Kanjer K; Hamann U
    Cancer Lett; 2012 Aug; 321(1):73-9. PubMed ID: 22366496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct mRNA, protein expression patterns and distribution of oestrogen receptors alpha and beta in human primary breast cancer: correlation with proliferation marker Ki-67 and clinicopathological factors.
    Jarzabek K; Koda M; Kozlowski L; Mittre H; Sulkowski S; Kottler ML; Wolczynski S
    Eur J Cancer; 2005 Dec; 41(18):2924-34. PubMed ID: 16289616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer.
    Campbell-Thompson M; Lynch IJ; Bhardwaj B
    Cancer Res; 2001 Jan; 61(2):632-40. PubMed ID: 11212261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of estrogen receptor beta isoform expression and its correlation with aberrant DNA methylation of the 5'-untranslated region in human epithelial ovarian carcinoma.
    Suzuki F; Akahira J; Miura I; Suzuki T; Ito K; Hayashi S; Sasano H; Yaegashi N
    Cancer Sci; 2008 Dec; 99(12):2365-72. PubMed ID: 19032364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of ERalpha, ERbeta and PR in lobular carcinoma in situ of the breast determined using laser microdissection and real-time PCR.
    Green AR; Young P; Krivinskas S; Rakha EA; Claire Paish E; Powe DG; Ellis IO
    Histopathology; 2009 Mar; 54(4):419-27. PubMed ID: 19309393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of promoter hypermethylation of ERβ and RARβ2 in tumor and serum DNA in Indian breast cancer patients.
    Mirza S; Sharma G; Parshad R; Srivastava A; Gupta SD; Ralhan R
    Ann Surg Oncol; 2012 Sep; 19(9):3107-15. PubMed ID: 22451234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer.
    Bièche I; Parfait B; Laurendeau I; Girault I; Vidaud M; Lidereau R
    Oncogene; 2001 Dec; 20(56):8109-15. PubMed ID: 11781824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducible upregulation of oestrogen receptor-beta1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells.
    Murphy LC; Peng B; Lewis A; Davie JR; Leygue E; Kemp A; Ung K; Vendetti M; Shiu R
    J Mol Endocrinol; 2005 Apr; 34(2):553-66. PubMed ID: 15821116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor alpha-negative breast cancer tissues express significant levels of estrogen-independent transcription factors, ERbeta1 and ERbeta5: potential molecular targets for chemoprevention.
    Poola I; Fuqua SA; De Witty RL; Abraham J; Marshallack JJ; Liu A
    Clin Cancer Res; 2005 Oct; 11(20):7579-85. PubMed ID: 16243834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous CXCL12 and ESR1 CpG island hypermethylation correlates with poor prognosis in sporadic breast cancer.
    Ramos EA; Camargo AA; Braun K; Slowik R; Cavalli IJ; Ribeiro EM; Pedrosa Fde O; de Souza EM; Costa FF; Klassen G
    BMC Cancer; 2010 Jan; 10():23. PubMed ID: 20109227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.